Replies to post #4910 on Insmed Inc (INSM)

[mpetisth1]

Also From Settlement:
In the case of an opt-in, Insmed will retain development control prior to approval, and Tercica or Genentech would gain commercial control after approval.

http://biz.yahoo.com/bw/070306/20070306006402.html?.v=1